JP2015501782A5 - - Google Patents

Download PDF

Info

Publication number
JP2015501782A5
JP2015501782A5 JP2014539984A JP2014539984A JP2015501782A5 JP 2015501782 A5 JP2015501782 A5 JP 2015501782A5 JP 2014539984 A JP2014539984 A JP 2014539984A JP 2014539984 A JP2014539984 A JP 2014539984A JP 2015501782 A5 JP2015501782 A5 JP 2015501782A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
heteroaryl
group
perfluoroalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014539984A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015501782A (ja
JP6215832B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/061597 external-priority patent/WO2013066684A1/en
Publication of JP2015501782A publication Critical patent/JP2015501782A/ja
Publication of JP2015501782A5 publication Critical patent/JP2015501782A5/ja
Application granted granted Critical
Publication of JP6215832B2 publication Critical patent/JP6215832B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014539984A 2011-11-04 2012-10-24 アミノピリミジンキナーゼ阻害剤 Expired - Fee Related JP6215832B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161555617P 2011-11-04 2011-11-04
US61/555,617 2011-11-04
PCT/US2012/061597 WO2013066684A1 (en) 2011-11-04 2012-10-24 Aminopyrimidine kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2015501782A JP2015501782A (ja) 2015-01-19
JP2015501782A5 true JP2015501782A5 (https=) 2015-12-17
JP6215832B2 JP6215832B2 (ja) 2017-10-18

Family

ID=47116510

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014539984A Expired - Fee Related JP6215832B2 (ja) 2011-11-04 2012-10-24 アミノピリミジンキナーゼ阻害剤

Country Status (14)

Country Link
US (3) US8927525B2 (https=)
EP (1) EP2776432B1 (https=)
JP (1) JP6215832B2 (https=)
KR (1) KR101990605B1 (https=)
CN (1) CN104011046B (https=)
AU (1) AU2012332931B2 (https=)
BR (1) BR112014010563B1 (https=)
CA (1) CA2853454C (https=)
ES (1) ES2629690T3 (https=)
IL (1) IL232234A0 (https=)
MX (1) MX347191B (https=)
PL (1) PL2776432T3 (https=)
RU (1) RU2674017C2 (https=)
WO (1) WO2013066684A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2516425T3 (pl) * 2009-12-23 2016-03-31 Jasco Pharmaceuticals Llc Inhibitory kinaz aminopirydynowych
EP2699569B1 (en) * 2011-04-22 2017-08-30 Jasco Pharmaceuticals, LLC Aminopyrimidine kinase inhibitors
EP2776432B1 (en) 2011-11-04 2017-03-29 Jasco Pharmaceuticals LLC Aminopyrimidine kinase inhibitors
JP6437452B2 (ja) 2013-01-14 2018-12-12 インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation Pimキナーゼ阻害剤として有用な二環式芳香族カルボキサミド化合物
RS60244B1 (sr) 2013-01-15 2020-06-30 Incyte Holdings Corp Jedinjenja tiazolkarboksamida i piridinkarboksamida korisna kao inhibitori pim kinaze
CN105658653A (zh) 2013-08-23 2016-06-08 因赛特公司 可用作pim激酶抑制剂的呋喃并-和噻吩并-吡啶甲酰胺化合物
US9580418B2 (en) 2014-07-14 2017-02-28 Incyte Corporation Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
WO2016010897A1 (en) 2014-07-14 2016-01-21 Incyte Corporation Bicyclic heteroaromatic carboxamide compounds useful as pim kinase inhibitors
WO2016196244A1 (en) 2015-05-29 2016-12-08 Incyte Corporation Pyridineamine compounds useful as pim kinase inhibitors
MX384172B (es) * 2015-08-04 2025-03-14 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd Derivados de pirazol pirimidina y sus usos.
TWI734699B (zh) 2015-09-09 2021-08-01 美商英塞特公司 Pim激酶抑制劑之鹽
US9920032B2 (en) 2015-10-02 2018-03-20 Incyte Corporation Heterocyclic compounds useful as pim kinase inhibitors
TW201837027A (zh) 2017-02-01 2018-10-16 以色列商以色列耶路撒冷希伯來大學伊索研究發展有限公司 吡唑衍生物及其用途
AR113922A1 (es) 2017-12-08 2020-07-01 Incyte Corp Terapia de combinación de dosis baja para el tratamiento de neoplasias mieloproliferativas
TW202128664A (zh) 2019-10-09 2021-08-01 德商拜耳廠股份有限公司 作為除害劑之新穎雜芳基三唑化合物
TW202542149A (zh) * 2023-12-21 2025-11-01 英商葛蘭素史密斯克藍智慧財產權有限公司 化合物及其用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW245716B (https=) 1992-12-28 1995-04-21 Takeda Pharm Industry Co
US5955481A (en) 1994-03-28 1999-09-21 Nissan Chemical Industries, Ltd. Pyridine type thiazolidines
IL113112A (en) * 1994-03-28 2000-06-01 Nissan Chemical Ind Ltd Pyridine substituted thiazolidinediones and pharmaceutical compositions comprising them
AU712802B2 (en) 1994-10-20 1999-11-18 Nippon Chemiphar Co. Ltd. Quinoline derivatives
RU2007101544A (ru) 2004-06-17 2008-08-10 Уайт (Us) Антагонисты рецепторов высвобождающего гонадотропин гормона
CA2576765C (en) 2004-09-03 2013-05-28 Applied Research Systems Ars Holding N.V. Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors
AU2005293556A1 (en) 2004-10-12 2006-04-20 Merck Serono Sa PI3 Kinase gamma inhibitors for the treatment of anaemia
EP1916249A1 (en) 2006-10-10 2008-04-30 LEK Pharmaceuticals D.D. 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents
EP2217235A4 (en) 2007-11-15 2011-01-12 Musc Found For Res Dev INHIBITORS OF PIM PROTEIN KINASES, COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
WO2009097113A2 (en) 2008-01-28 2009-08-06 New York University Oxazole and thiazole compounds as b-catenin modulators and uses thereof
WO2010056549A1 (en) 2008-10-29 2010-05-20 Sirtris Pharmaceuticals, Inc. Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
US20100331315A1 (en) * 2009-06-18 2010-12-30 Mustapha Haddach Rhodanines and related heterocycles as kinase inhibitors
PL2516425T3 (pl) * 2009-12-23 2016-03-31 Jasco Pharmaceuticals Llc Inhibitory kinaz aminopirydynowych
EP2699569B1 (en) * 2011-04-22 2017-08-30 Jasco Pharmaceuticals, LLC Aminopyrimidine kinase inhibitors
EP2776432B1 (en) 2011-11-04 2017-03-29 Jasco Pharmaceuticals LLC Aminopyrimidine kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2015501782A5 (https=)
RU2014122344A (ru) Аминопиримидиновые ингибиторы киназ
RU2477723C2 (ru) Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
JP2019518766A5 (https=)
ME02452B (me) Sredstva za induciranje apoptoze namijenjena liječenju raka i imunih i autoimunih bolesti
JP2013535491A5 (https=)
JP2014520898A5 (https=)
RU2019142795A (ru) Производное n-(азаарил)циклолактам-1-карбоксамида, метод его получения и его применение
RU2018138828A (ru) Уменьшение массы опухоли путем введения ccr1 антагонистов в комбинации с pd-1 ингибиторами или pd-l1 ингибиторами
JP2009263394A5 (https=)
JP2012153722A5 (https=)
JP2015531747A5 (https=)
JP2013502441A5 (https=)
CN106660974A (zh) 含氨磺酰基的1,2,5‑噁二唑类衍生物、其制备方法及其在医药上的应用
RU2019101220A (ru) Кристаллические формы соединения триазолопиримидина
RU2016143333A (ru) Амидные производные и их фармацевтически приемлемые соли, способ их получения и медицинское применение
ME02838B (me) 3,4-dihidroizokinolin-2(1h)-ilni spojevi
JP2013509431A5 (https=)
JP2017502940A5 (https=)
JP2017508782A5 (https=)
JP2011502956A5 (https=)
RU2017104856A (ru) Функционализированные и замещенные индолы в качестве противораковых средств
JP2015511232A5 (https=)
JP2021513984A5 (https=)
JP2013520443A5 (https=)